<?xml version="1.0" encoding="UTF-8"?>
<gtr:projectOverview xmlns:gtr="http://gtr.ukri.org/api"><gtr:projectComposition><gtr:collaborations><gtr:collaborator url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address></gtr:collaborator><gtr:collaborator url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address></gtr:collaborator></gtr:collaborations><gtr:leadResearchOrganisation url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:department>Biomedical Sciences</gtr:department><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:typeInd>RO</gtr:typeInd></gtr:leadResearchOrganisation><gtr:organisationRoles><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/F7E13617-2678-475B-99E4-31479C92038D"><gtr:id>F7E13617-2678-475B-99E4-31479C92038D</gtr:id><gtr:name>University of Aberdeen</gtr:name><gtr:address><gtr:line1>University Office</gtr:line1><gtr:line2>Regent Walk</gtr:line2><gtr:line4>Aberdeen</gtr:line4><gtr:line5>Aberdeenshire</gtr:line5><gtr:postCode>AB24 3FX</gtr:postCode><gtr:region>Scotland</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>LEAD_RO</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/46387D84-F71E-4B7D-8C7D-9C288F113510"><gtr:id>46387D84-F71E-4B7D-8C7D-9C288F113510</gtr:id><gtr:name>Imperial College London</gtr:name><gtr:address><gtr:line1>South Kensington Campus</gtr:line1><gtr:line2>Exhibition Road</gtr:line2><gtr:line4>London</gtr:line4><gtr:postCode>SW7 2AZ</gtr:postCode><gtr:region>London</gtr:region><gtr:country>United Kingdom</gtr:country></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole><gtr:organisationRole url="http://gtr.ukri.org:80/organisation/78308CAA-8483-45C0-A280-0AB4B6AD9D35"><gtr:id>78308CAA-8483-45C0-A280-0AB4B6AD9D35</gtr:id><gtr:name>Medical Research Council</gtr:name><gtr:address><gtr:line1>Polaris House</gtr:line1><gtr:line2>North Star Avenue</gtr:line2><gtr:postCode>SN2 1FL</gtr:postCode><gtr:region>South West</gtr:region></gtr:address><gtr:roles><gtr:role><gtr:name>COLLABORATOR</gtr:name></gtr:role></gtr:roles></gtr:organisationRole></gtr:organisationRoles><gtr:personRoles><gtr:personRole url="http://gtr.ukri.org:80/person/713039D9-A6D6-40E0-88B1-32C5AAA4EC4B"><gtr:id>713039D9-A6D6-40E0-88B1-32C5AAA4EC4B</gtr:id><gtr:firstName>William</gtr:firstName><gtr:surname>Wisden</gtr:surname><gtr:roles><gtr:role><gtr:name>PRINCIPAL_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole><gtr:personRole url="http://gtr.ukri.org:80/person/567827DE-34A2-4CFD-9DEE-7A123F17CDF3"><gtr:id>567827DE-34A2-4CFD-9DEE-7A123F17CDF3</gtr:id><gtr:firstName>Peer</gtr:firstName><gtr:surname>Wulff</gtr:surname><gtr:roles><gtr:role><gtr:name>CO_INVESTIGATOR</gtr:name></gtr:role></gtr:roles></gtr:personRole></gtr:personRoles><gtr:project url="http://gtr.ukri.org:80/projects?ref=G0601498"><gtr:id>091C0800-C304-4F64-B579-244F8DDDB692</gtr:id><gtr:title>GABAergic interneurones and schizophrenia</gtr:title><gtr:status>Closed</gtr:status><gtr:grantCategory>Research Grant</gtr:grantCategory><gtr:grantReference>G0601498</gtr:grantReference><gtr:abstractText>Schizophrenia badly affects those that suffer from it. Well known symptoms include hearing voices or other hallucinations. These symptoms can be treated, to some extent, with existing medicines. But there are other problems: patients have disorganized, slow thinking; they have poor concentration, and poor memory. This means that patients with schizophrenia often cannot organize their everyday lives. Drugs that would improve the thinking and memory abilities of patients are much needed. To invent new drugs requires understanding the brain circuits needed for thinking and memory. We and other researchers believe that a specific type of brain cell has gone wrong in schizophrenia, and that these cells are not wired up properly. This type of cell usually says no to other cells. But more than just saying no, these are master command cells; they say no to many thousands of other brain cells all at once. Patients with schizophrenia may have faulty command cells that do not properly say no. Using genetically altered mice, we plan to model and study the master brain cells and learn how they work. We hope that our research will one day lead to better drugs that help patients improve their memory and thinking.</gtr:abstractText><gtr:technicalSummary>Schizophrenia affects approximately 1% of the population. Patients suffer from psychosis (delusions, perceptual disturbances and hallucinations) and disruptions in cognitive functions: attention, working memory and planned behaviour. Medication reduces the psychosis but not the cognitive impairments; unfortunately, it is the latter that most hinder daily life and their extent best predicts long-term outcome. A central hypothesis is that cognitive processing is reflected by variations in the external electrical field ? e.g. gamma (30-90Hz) oscillations. Cognitive theories predict that oscillations provide reference signals for representing, processing and storing information by transiently synchronized groups of neurons. In patients suffering from schizophrenia, gamma is reduced, and may underlie the cognitive deficits. To develop targeted treatments for the cognitive defects will require greater knowledge of the circuits that govern working memory (the ability to keep events ?in mind? for short time periods). In spite of our increasing knowledge about the ?wiring diagram? of the hippocampus and neocortex, little is known about the specific contributions that the diverse interneurone types make to behaviour. We propose to study unique models we have generated that would (1) inform on how gamma oscillations are regulated; (2) permit for the first time these oscillations to be reversibly and selectively manipulated to see if this correlates with behaviour (working memory); and (3) reveal if GABA-A receptor signalling shapes the establishment of this neuronal network during development. We would:
(A) functionally and selectively remove parvalbumin-expressing interneurons from local circuits. This will enable us to test if long-term malfunctions of this cell class produce and phenocopy the change in network activity found in schizophrenia. Will removal of parvalbumin cells impair working memory, defined as the cognitive process that stores and manipulates information relevant only for a short period of time during an experimental session?
(B) refine a new and original approach we have developed (the ?zolpidem method?) to dissect circuit components.
(C) use the ?zolpidem method? to selectively and reversibly increase GABAergic drive onto hippocampal and fronto-cortical parvalbumin-containing cells in vivo, and study the consequences to see if (i) gamma oscillations are reversibly decreased; and (ii) if this decrease can be correlated with poorer working memory. 
(D) use a GABA-A receptor ?g2 knockdown? to analyse how GABA transmission affects the phenotype of GABAergic neurons in the neocortex.</gtr:technicalSummary><gtr:fund><gtr:end>2010-08-31</gtr:end><gtr:funder url="http://gtr.ukri.org:80/organisation/C008C651-F5B0-4859-A334-5F574AB6B57C"><gtr:id>C008C651-F5B0-4859-A334-5F574AB6B57C</gtr:id><gtr:name>MRC</gtr:name></gtr:funder><gtr:start>2007-06-01</gtr:start><gtr:type>INCOME_ACTUAL</gtr:type><gtr:valuePounds>463162</gtr:valuePounds></gtr:fund><gtr:output><gtr:artisticAndCreativeProductOutputs/><gtr:collaborationOutputs><gtr:collaborationOutput><gtr:collaboratingOrganisation>Medical Research Council (MRC)</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:department>MRC Laboratory of Molecular Biology (LMB)</gtr:department><gtr:description>BBSRC histamine</gtr:description><gtr:id>432F0354-9ACB-4D58-A1CF-B418C5C33D23</gtr:id><gtr:impact>So far, it helped us win a BBSRC grant</gtr:impact><gtr:outcomeId>bb47rZGZwTW-1</gtr:outcomeId><gtr:partnerContribution>They provided a specialist technique</gtr:partnerContribution><gtr:piContribution>The team at MRC-LMB helped us win a BBSRC project grant</gtr:piContribution><gtr:sector>Public</gtr:sector><gtr:start>2013-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC programme grant &amp;quot;Neuronal Pathways of Sleep and Anaesthesia&amp;quot;</gtr:description><gtr:id>66652B84-38CE-442F-9062-1922DAD67AB7</gtr:id><gtr:impact>Multidisciplinary collaboration. anaesthetic mechanisms and physics; molecular neuroscience and mouse genetics; neuronal electrophysiology; inh vivo recording</gtr:impact><gtr:outcomeId>YnC163C9BHQ-1</gtr:outcomeId><gtr:partnerContribution>multidisciplinary inputs - hugely stimulating intellectual contributions and discussions, and knowledege of EEG receording and neurophsyiology</gtr:partnerContribution><gtr:piContribution>Our team at the South Kensington Campus of Imperial College London has a unique combination of expertise and experience. Franks' knowledge of anaesthetic mechanisms and physics background, Wisden's knowledge of molecular neuroscience and mouse genetics, and Brickley's experience of neuronal electrophysiology and ion channels form the core; in addition we have experienced chemists who
work with us</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2010-01-01</gtr:start></gtr:collaborationOutput><gtr:collaborationOutput><gtr:collaboratingOrganisation>Imperial College London</gtr:collaboratingOrganisation><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:description>MRC project grant &amp;quot;Sleep Pathways and General Anaesthesia&amp;quot;</gtr:description><gtr:id>6D289617-6583-4DC2-9165-FA9C069250A2</gtr:id><gtr:impact>PMID: 17572671 [PubMed - indexed for MEDLINE] PMID: 19805135 [PubMed - indexed for MEDLINE]</gtr:impact><gtr:outcomeId>B18400A7245-1</gtr:outcomeId><gtr:partnerContribution>It helped consolidate a long-term research grouping between myself, Prof. Nick Franks (Imperial College London) and Dr Stephen Brickley (Imperial College London)</gtr:partnerContribution><gtr:piContribution>We developed a novel mouse genetics method to manipulate the activity of specific subtypes of neuron. We developed potassium channel knockout mouse lines.</gtr:piContribution><gtr:sector>Academic/University</gtr:sector><gtr:start>2006-01-01</gtr:start></gtr:collaborationOutput></gtr:collaborationOutputs><gtr:disseminationOutputs><gtr:disseminationOutput><gtr:description>Radio interview</gtr:description><gtr:form>A press release, press conference or response to a media enquiry/interview</gtr:form><gtr:geographicReach>National</gtr:geographicReach><gtr:id>2A1ED735-C732-4760-A0E9-BEC91D629BBF</gtr:id><gtr:impact>see: http://www.abdn.ac.uk/news/archive-details-3923.php The co PI on the grant, Dr Peer Wulff, was interviewed about the Wulff et al 2009 PNAS paper on Scottish BBC radio and in the local press.

enhanced public understanding and interest</gtr:impact><gtr:outcomeId>A74EE2676B3</gtr:outcomeId><gtr:partOfOfficialScheme>false</gtr:partOfOfficialScheme><gtr:primaryAudience>Public/other audiences</gtr:primaryAudience><gtr:url>http://www.abdn.ac.uk/news/archive-details-3923.php</gtr:url><gtr:year>2009</gtr:year></gtr:disseminationOutput></gtr:disseminationOutputs><gtr:exploitationOutputs/><gtr:furtherFundingOutputs><gtr:furtherFundingOutput><gtr:amountPounds>1000000</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:department>Wellcome Trust Senior Investigator Award</gtr:department><gtr:description>Wellcome Trust Investigator Awrad</gtr:description><gtr:end>2021-09-02</gtr:end><gtr:fundingOrg>Wellcome Trust</gtr:fundingOrg><gtr:fundingRef>107841/Z/15/Z</gtr:fundingRef><gtr:id>07C1BF04-0981-476E-96D9-D93BA4A1B1DF</gtr:id><gtr:outcomeId>56d96cfaee4249.63732233</gtr:outcomeId><gtr:sector>Private</gtr:sector><gtr:start>2015-10-01</gtr:start></gtr:furtherFundingOutput><gtr:furtherFundingOutput><gtr:amountPounds>1094760</gtr:amountPounds><gtr:country>United Kingdom of Great Britain &amp; Northern Ireland (UK)</gtr:country><gtr:currCode>GBP</gtr:currCode><gtr:currCountryCode>United Kingdom</gtr:currCountryCode><gtr:currLang>en_GB</gtr:currLang><gtr:description>MRC Programme Grant G0901892</gtr:description><gtr:end>2014-10-02</gtr:end><gtr:fundingOrg>Medical Research Council (MRC)</gtr:fundingOrg><gtr:id>6C1B8C65-1EED-491C-8E40-908B5775067A</gtr:id><gtr:outcomeId>DE150984C100</gtr:outcomeId><gtr:sector>Academic/University</gtr:sector><gtr:start>2009-10-01</gtr:start></gtr:furtherFundingOutput></gtr:furtherFundingOutputs><gtr:impactSummaryOutputs/><gtr:intellectualPropertyOutputs/><gtr:otherResearchOutputs/><gtr:policyInfluenceOutputs/><gtr:productOutputs/><gtr:researchDatabaseAndModelOutputs/><gtr:researchMaterialOutputs><gtr:researchMaterialOutput><gtr:description>A series of plasmids deposited at Addgene. these plasmids were used in two of our papers in 2015. Zhang et al. Nat Neurosci and Yu et al Neuron.</gtr:description><gtr:id>B106CBBB-F35B-4FA2-835E-D4841EF34AD2</gtr:id><gtr:impact>The plasmids will be broadly useful to various neuroscientists.</gtr:impact><gtr:outcomeId>56d880f7d554f1.75407903</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>Plasmid deposits at Addgene</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>https://www.addgene.org/William_Wisden/</gtr:url><gtr:yearFirstProvided>2016</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>In mammals, identifying the contribution of specific neurons or networks to behavior is a key challenge. Here we describe an approach that facilitates this process by enabling the rapid modulation of synaptic inhibition in defined cell populations. Binding of zolpidem, a systemically active allosteric modulator that enhances the function of the GABA-A receptor, requires a phenylalanine residue (Phe77) in the gamma2 subunit. Mice in which this residue is changed to isoleucine are insensitive to zolpidem. By Cre recombinase-induced swapping of the gamma2 subunit (that is, exchanging Ile77 for Phe77), zolpidem sensitivity can be restored to GABA-A receptors in chosen cell types. We demonstrated the power of this method in the cerebellum, where zolpidem rapidly induces significant motor deficits when Purkinje cells are made uniquely sensitive to its action. This combined molecular and pharmacological technique has demonstrable advantages over targeted cell ablation and will be invaluable for investigating many neuronal circuits. Wulff P, Goetz T, Leppa E, Linden AM, Renzi M, Swinny JD, Vekovischeva OY, Sieghart W, Somogyi P, Korpi ER, Farrant M, Wisden W (2007) From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors. Nat Neurosci 10:923-929.</gtr:description><gtr:id>83A954FC-0341-4A56-A8B2-12C73DD359C5</gtr:id><gtr:impact>The method, which involves mouse genetics, generated a lot of interest.</gtr:impact><gtr:outcomeId>27939AF528F</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>zolpidem method</gtr:title><gtr:type>Model of mechanisms or symptoms - mammalian in vivo</gtr:type><gtr:yearFirstProvided>2008</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>This is a gene which stops neurotransmission when activated by cre recombinase. It will be a useful reagent for cell-type selective analysis of gene circuitry (Murray et al., 2011 Nat Neurosci).</gtr:description><gtr:id>15B64188-282D-4E77-B397-8BCB64CEE306</gtr:id><gtr:impact>in progress</gtr:impact><gtr:outcomeId>iBHTKTALWcV</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>AAV-flex switch tet toxin</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:yearFirstProvided>2011</gtr:yearFirstProvided></gtr:researchMaterialOutput><gtr:researchMaterialOutput><gtr:description>Mouse line with Cre recombinase selectively expressed in cells that express histidine decarboxylase</gtr:description><gtr:id>803D8A88-070E-4472-9ED1-0B462EA1A0C3</gtr:id><gtr:impact>deposited at the JAX labs in 2013</gtr:impact><gtr:outcomeId>p9zBRR6bGvH</gtr:outcomeId><gtr:providedToOthers>true</gtr:providedToOthers><gtr:title>HDC-Cre</gtr:title><gtr:type>Technology assay or reagent</gtr:type><gtr:url>https://www.jax.org/strain/021198</gtr:url><gtr:yearFirstProvided>2012</gtr:yearFirstProvided></gtr:researchMaterialOutput></gtr:researchMaterialOutputs><gtr:softwareAndTechnicalProductOutputs/><gtr:spinOutOutputs/></gtr:output><gtr:publications><gtr:publication><gtr:id>27DE24AB-7017-4877-A5BC-73F7F08FDE25</gtr:id><gtr:title>GABA(A) receptors: structure and function in the basal ganglia.</gtr:title><gtr:parentPublicationTitle>Progress in brain research</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/44ebc0d38e0ae20bd3320656d470aeab"><gtr:id>44ebc0d38e0ae20bd3320656d470aeab</gtr:id><gtr:otherNames>Goetz T</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>0079-6123</gtr:issn><gtr:outcomeId>pm_12803_13_17499107</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>CA4AA294-A270-4E09-ABE2-B3BA395C4ACD</gtr:id><gtr:title>The role of K2p channels in anaesthesia and sleep.</gtr:title><gtr:parentPublicationTitle>Pflugers Archiv : European journal of physiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/fc4a6734588d9a5f972897c64738d71b"><gtr:id>fc4a6734588d9a5f972897c64738d71b</gtr:id><gtr:otherNames>Steinberg EA</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0031-6768</gtr:issn><gtr:outcomeId>doi_55f984984a842859</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>B4CDFA6D-C0A3-4C74-982F-5AE360B38168</gtr:id><gtr:title>Altered activity in the central medial thalamus precedes changes in the neocortex during transitions into both sleep and propofol anesthesia.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/d8960949b7145d41cb88c41c76118195"><gtr:id>d8960949b7145d41cb88c41c76118195</gtr:id><gtr:otherNames>Baker R</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>545bab13e41b99.84365090</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>4F9E194D-4797-4E0F-A79F-AD4F82D16F8A</gtr:id><gtr:title>Staying awake--a genetic region that hinders a2 adrenergic receptor agonist-induced sleep.</gtr:title><gtr:parentPublicationTitle>The European journal of neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0530e1852c351609e066946ac4400ce8"><gtr:id>0530e1852c351609e066946ac4400ce8</gtr:id><gtr:otherNames>Gelegen C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0953-816X</gtr:issn><gtr:outcomeId>545bab13b986e9.63574345</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>746AC8B5-4F3D-4FA5-8E52-8C1E90B4F213</gtr:id><gtr:title>Hippocampal theta rhythm and its coupling with gamma oscillations require fast inhibition onto parvalbumin-positive interneurons.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fa4b9182d9799a1011b1892ff62a47d"><gtr:id>5fa4b9182d9799a1011b1892ff62a47d</gtr:id><gtr:otherNames>Wulff P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>6946099AE75</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>F9396269-4867-44A4-B925-56BD280899B5</gtr:id><gtr:title>Chemical genetics: receptor-ligand pairs for rapid manipulation of neuronal activity.</gtr:title><gtr:parentPublicationTitle>Current opinion in neurobiology</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fa4b9182d9799a1011b1892ff62a47d"><gtr:id>5fa4b9182d9799a1011b1892ff62a47d</gtr:id><gtr:otherNames>Wulff P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0959-4388</gtr:issn><gtr:outcomeId>pm_12803_23_22119143</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>65CF6449-416C-4720-BD98-1A1B1FAAF421</gtr:id><gtr:title>Removal of GABA(A) receptor ?2 subunits from parvalbumin neurons causes wide-ranging behavioral alterations.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/40065437a72da751d3e0dccb165931e6"><gtr:id>40065437a72da751d3e0dccb165931e6</gtr:id><gtr:otherNames>Lepp? E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>siNWSHrd5Hi</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>31A5869D-DECD-4718-9CD8-B60F053FCDFD</gtr:id><gtr:title>Quantitative organization of GABAergic synapses in the molecular layer of the mouse cerebellar cortex.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/b53d26c88fd4f3b4055dc444b1c8a1bf"><gtr:id>b53d26c88fd4f3b4055dc444b1c8a1bf</gtr:id><gtr:otherNames>Briatore F</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2010-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>qCuG9FCeunD</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>18ADD919-BDBA-40C1-B678-D65BF6BB5B3F</gtr:id><gtr:title>GABAergic inhibition of histaminergic neurons regulates active waking but not the sleep-wake switch or propofol-induced loss of consciousness.</gtr:title><gtr:parentPublicationTitle>The Journal of neuroscience : the official journal of the Society for Neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/838b7b52121a0eeeec8709ae049f60cb"><gtr:id>838b7b52121a0eeeec8709ae049f60cb</gtr:id><gtr:otherNames>Zecharia AY</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2012-01-01</gtr:date><gtr:issn>0270-6474</gtr:issn><gtr:outcomeId>pm_12803_23_22993424</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>91A529A4-72E2-4CB3-B78B-08639538B563</gtr:id><gtr:title>Wakefulness Is Governed by GABA and Histamine Cotransmission.</gtr:title><gtr:parentPublicationTitle>Neuron</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1879cf77e5158dd3c9b1fb0724cc2274"><gtr:id>1879cf77e5158dd3c9b1fb0724cc2274</gtr:id><gtr:otherNames>Yu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>0896-6273</gtr:issn><gtr:outcomeId>5675e6fcdfa82</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>E1CE7DE4-C20D-4848-8C04-95BCAD94B6F0</gtr:id><gtr:title>Production and titering of recombinant adeno-associated viral vectors.</gtr:title><gtr:parentPublicationTitle>Journal of visualized experiments : JoVE</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/7626a4766d271d00a8558058348ade5a"><gtr:id>7626a4766d271d00a8558058348ade5a</gtr:id><gtr:otherNames>McClure C</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1940-087X</gtr:issn><gtr:outcomeId>pm_12803_23_22143312</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>ABA487A1-3BD4-41C3-8E0A-549E88934377</gtr:id><gtr:title>Synaptic competition sculpts the development of GABAergic axo-dendritic but not perisomatic synapses.</gtr:title><gtr:parentPublicationTitle>PloS one</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/f0fe2f28512a3f63c7a45952567f4f53"><gtr:id>f0fe2f28512a3f63c7a45952567f4f53</gtr:id><gtr:otherNames>Frola E</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2013-01-01</gtr:date><gtr:issn>1932-6203</gtr:issn><gtr:outcomeId>pm_12803_23_23457547</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>1691D3B0-4733-42E1-A08B-0DE677257975</gtr:id><gtr:title>Studying Cerebellar Circuits by Remote Control of Selected Neuronal Types with GABA(A) Receptors.</gtr:title><gtr:parentPublicationTitle>Frontiers in molecular neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/9e0181e245741c76607ef87f1872b51b"><gtr:id>9e0181e245741c76607ef87f1872b51b</gtr:id><gtr:otherNames>Wisden W</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1662-5099</gtr:issn><gtr:outcomeId>n3t97hE4NeX</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>21B58CEA-C7FC-401D-8F7C-F62EECE549CF</gtr:id><gtr:title>From synapse to behavior: rapid modulation of defined neuronal types with engineered GABAA receptors.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fa4b9182d9799a1011b1892ff62a47d"><gtr:id>5fa4b9182d9799a1011b1892ff62a47d</gtr:id><gtr:otherNames>Wulff P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2007-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>qN5LSSPb6wn</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>885F1830-DA74-426E-A632-408B53AA33CD</gtr:id><gtr:title>An unexpected role for TASK-3 potassium channels in network oscillations with implications for sleep mechanisms and anesthetic action.</gtr:title><gtr:parentPublicationTitle>Proceedings of the National Academy of Sciences of the United States of America</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/129ab53db74cdd13ecf97b8d5b727a4e"><gtr:id>129ab53db74cdd13ecf97b8d5b727a4e</gtr:id><gtr:otherNames>Pang DS</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>0027-8424</gtr:issn><gtr:outcomeId>sefceezBARa</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7ACD7BBD-C0F5-4CE7-9EE7-A61B893FE9C5</gtr:id><gtr:title>Parvalbumin-positive CA1 interneurons are required for spatial working but not for reference memory.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac60c126dd05fe5ce69dfda4816f4de9"><gtr:id>ac60c126dd05fe5ce69dfda4816f4de9</gtr:id><gtr:otherNames>Murray AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2011-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>B2388121_8B2388121_8</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>2E109D83-0836-4A2B-9716-02BA41369888</gtr:id><gtr:title>Circadian factor BMAL1 in histaminergic neurons regulates sleep architecture.</gtr:title><gtr:parentPublicationTitle>Current biology : CB</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/1879cf77e5158dd3c9b1fb0724cc2274"><gtr:id>1879cf77e5158dd3c9b1fb0724cc2274</gtr:id><gtr:otherNames>Yu X</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2014-01-01</gtr:date><gtr:issn>0960-9822</gtr:issn><gtr:outcomeId>doi_55f984984a8e5c54</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>24FBCF1C-7F37-4B7C-AAC8-1D3DA566F780</gtr:id><gtr:title>Synaptic inhibition of Purkinje cells mediates consolidation of vestibulo-cerebellar motor learning.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/5fa4b9182d9799a1011b1892ff62a47d"><gtr:id>5fa4b9182d9799a1011b1892ff62a47d</gtr:id><gtr:otherNames>Wulff P</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2009-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>bdrmcsXGCSv</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>7A9D721F-D6EB-4885-A844-582A7FD8F452</gtr:id><gtr:title>Neuronal ensembles sufficient for recovery sleep and the sedative actions of a2 adrenergic agonists.</gtr:title><gtr:parentPublicationTitle>Nature neuroscience</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/0355658aee7a567caa922e6adbda88b6"><gtr:id>0355658aee7a567caa922e6adbda88b6</gtr:id><gtr:otherNames>Zhang Z</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>1097-6256</gtr:issn><gtr:outcomeId>doi_55f94d94df94f22a</gtr:outcomeId></gtr:publication><gtr:publication><gtr:id>0228663B-F41C-474C-960E-476C4F1CCB67</gtr:id><gtr:title>Parvalbumin-positive interneurons of the prefrontal cortex support working memory and cognitive flexibility.</gtr:title><gtr:parentPublicationTitle>Scientific reports</gtr:parentPublicationTitle><gtr:authors><gtr:author url="http://gtr.ukri.org:80/person/ac60c126dd05fe5ce69dfda4816f4de9"><gtr:id>ac60c126dd05fe5ce69dfda4816f4de9</gtr:id><gtr:otherNames>Murray AJ</gtr:otherNames></gtr:author></gtr:authors><gtr:date>2015-01-01</gtr:date><gtr:issn>2045-2322</gtr:issn><gtr:outcomeId>585d5539c88037.07824943</gtr:outcomeId></gtr:publication></gtr:publications><gtr:identifiers><gtr:identifier type="RCUK">G0601498</gtr:identifier></gtr:identifiers><gtr:healthCategories><gtr:healthCategory><gtr:id>041997EB-CFD8-493D-B0F8-DFA35451D0BE</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>Neurological</gtr:text></gtr:healthCategory></gtr:healthCategories><gtr:researchActivities><gtr:researchActivity><gtr:id>CF950C9A-DB16-4E23-8AEB-94548777BCA1</gtr:id><gtr:percentage>100</gtr:percentage><gtr:text>1.1  Normal biological development and functioning</gtr:text></gtr:researchActivity></gtr:researchActivities><gtr:researchSubjects/><gtr:researchTopics/><gtr:rcukProgrammes/></gtr:project></gtr:projectComposition></gtr:projectOverview>